Publish with Us Search
Publish with Us

Targeted Cancer Therapy Connect

ISSN: 3078-154X
Volumes

SCIFINITI ALERT!

Subscribe for research updates and exclusive content straight to your inbox

Editorial Board

Eyad Elkord

Editor-in-Chief

Affiliation:
Department of Biological Sciences, School of Science
Xi’an Jiaotong-Liverpool University
Suzhou
China

Biography:
Professor Eyad Elkord is a distinguished cancer immunologist with different academic and leading positions at different institutions. He is an internationally influential researcher in oncoimmunology and cancer immunotherapy. Recognized for his research impact, he has been listed among Stanford University’s top 2% of scientists globally for four consecutive years.

Interests:
cancer immunology, cancer immunotherapy, tumor microenvironment, immune evasion, immunosuppression, immunomodulation

Afsheen Raza

Associate Editor

Affiliation:
Associate Professor of Molecular Biology
College of Health Science
Abu Dhabi University 
Abu Dhabi
UAE


Interests:
Predictive/prognostic tumor biomarkers, tumor-host immune interactions to immunotherapeutic strategies, Immune-monitoring tools of novel immune-modulators and cancer antigen specific immune cells, Translational and precision medicine tools such as liquid biopsy as biomarkers of response, Immune checkpoint inhibitors and immune modulatory vaccines as therapeutic targets, Lung cancer, Gastric cancer, Triple-negative breast cancer, Head and Neck cancers


David R. Minor

Associate Editor

Affiliation:
California Pacific Medical Center
San Francisco, CA
USA

Interests:
immunotherapy, skin cancer, second primary melanomas
Wamidh H. Talib

Associate Editor

Affiliation:
Applied Science Private University
Amman
Jordan

Interests:
complementary cancer therapies, anti-cancer nutrition, drug resistance of cancer cells, screening of anti-cancer substances
Jibran Sualeh Muhammad

Regional Editor

Affiliation:
College of Medicine and Health
University of Birmingham 
Birmingham
United Kingdom

Interests:
epigenetic modulation in carcinogenesis, immune disorders and infectious diseases


Mawieh Hamad

Regional Editor

Affiliation:
Department of Medical Laboratory Sciences
University of Sharjah
Sharjah
UAE

Region:
Middle East  

Interests:
molecular immunology,  human homeostasis, hemochromatosis, ferritin, iron metabolism

Simon Cocklin

Regional Editor

Affiliation:
Scientific Consultant
USA

Region:
North America

Interests:
Small molecules and biologics, surface plasmon resonance (SPR) interaction analysis and screening, translational medicine





Monther M. Al-Alwan

Section Editor

Affiliation:
Senior Scientist, Cell Therapy and Immunobiology Department
King Faisal Specialist Hospital and Research Centre
Riyadh
Saudi Arabia

Section Title:
Immune Cell Signaling in Cancer

Interests:
cancer, cancer stem cell, immunology, cell signaling. 
Varun Sasidharan Nair

Section Editor

Affiliation:
Italian Institute of Technology (IIT)
Genova
Italy

Section Title:
Epigenetic Regulation in Tumour Immunity

Interests:
immunology, epigenetics, cancer therapy
Abdelaziz Amrani

Editorial Board Member

Affiliation:
Dept of Pediatric, Immunology Division
Université de Sherbrooke
Sherbrooke
Canada

Interests:
immunoregulation, dendritic cells, T lymphocytes, cell signaling pathways, immunotherapy, autoimmune diseases (type 1 diabetes, multiple sclerosis and colitis, rheumatoid arthritis)
Alejandro Bravo-Cuellar

Editorial Board Member

Affiliation:
Immunology Division
CIBO-IMSS
Guadalajara
Mexico

Interests:
macrophages, Adriamycin, Pentoxifylline, Apoptosis
Azam Bolhassani

Editorial Board Member

Affiliation:
Pasteur Institute of Iran
Tehran
Iran

Interests:
Immunotherapy and chemotherapy, Delivery system and nanoparticles, Adjuvants, Vaccine design against HPV and HIV
Chandra Shekhar Boosani

Editorial Board Member

Affiliation:
Animal Science Division
University of Missouri
Columbia
USA

Interests:
Gene therapy, Vascular Research, Bio-therapeutics


Cristina Maccalli

Editorial Board Member

Affiliation:
Unit of Biotherapy, Center of Advanced Biotechnologies
San Martino Hospital-IRCCS
Genoa
Italy
&
Visiting Scientist
Sidra Medicine
Doha
Qatar

Interests:
tumor immunotherapy, cell therapy, engineered immune cells, immunoncology
Imran Shair Mohammad

Editorial Board Member

Affiliation:
Department of Interventional Radiology
City of Hope National Medical Center
Duarte, CA, 
USA


Interests:
Immuno-oncology, Drugs, gene, exosomes, protein delivery, Cancer multidrug resistance, Microbiome 



Julie Maria Jozefa Bouckaert

Editorial Board Member

Affiliation:
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF)
Villeneuve-d'Ascq
France

Interests:
TACA, paucimannose, IgM, AHNAK, crystal
Khaled M. Al-Qaoud

Editorial Board Member

Affiliation:
Faculty of Science
Department of Biological Sciences
Yarmouk University
Irbid
Jordan


Interests:
Immunology, Molecular Biology, Camel Antibodies, Biopharmaceuticals, Biotherapeutics


Nicolai Savaskan

Editorial Board Member

Affiliation:
Public Health Service Neukölln
Berlin
Germany


Interests:
Neuroscience, Cancer, Infection Control, Glutamate Signaling, Public Health, Migration, Mental Health


Orestis Ioannidis

Editorial Board Member

Affiliation:
Aristotle University of Thessaloniki
Thessaloniki
Greece

Interests:
laparoscopic surgery, surgical oncology, cancer, neoplasm, anticarcinogen
Paolo De Simone

Editorial Board Member

Affiliation:
Azienda Ospedaliero Universitaria Pisana
Pisa
Italy

Interests:
hepatocellular carcinoma, liver tumor, cancer, liver transplantation
Rupinder Kaur Kanwar

Editorial Board Member

Affiliation:
All India Institute of Medical Sciences Bhopal
Bhopal
India

Interests:
Translational Research, Oncology, Nanomedicine, Tissue engineering,  and Regenerative medicine




Sankar Bhattacharyya

Editorial Board Member

Affiliation:
Department of Zoology
Sidho Kanho Birsha University
Purulia
India 

Interests:
drug discovery studies in neoplastic diseases, chronic inflammatory disorders, study of the mechanism of tumor-immune system interaction, role of innate and immature myeloid cells in cancer and autoimmune diseases

Subramaniam Malarkannan

Editorial Board Member

Affiliation:
Medical College of Wisconsin
Milwaukee
United States

Interests:
NK cell-mediated immunotherapy, NK cells, metabolic reprogramming, T cell-mediated cellular immunotherapy
Thomas Kieber-Emmons

Editorial Board Member

Affiliation:
Department of Pathology
Winthrop P. Rockefeller Cancer Institute
University of Arkansas for Medical Sciences
Little Rock, AK
USA

Interests:
Vaccine Efficacy, Virus Antibody, Immunotherapy, Multiple Myeloma, T-Helper Cell, Tumor Antigen, Cancer Cell


Share
Help